{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:56:42Z","timestamp":1781639802784,"version":"3.54.5"},"reference-count":16,"publisher":"Norwegian Medical Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2016,1,12]]},"DOI":"10.4045\/tidsskr.14.1559","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T19:29:23Z","timestamp":1452713363000},"page":"32-4","source":"Crossref","is-referenced-by-count":1,"title":["Prevensjon for kvinner som bruker antiepileptika"],"prefix":"10.4045","volume":"136","author":[{"given":"Lillian","family":"Reiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1851-4857","authenticated-orcid":false,"given":"Karl O.","family":"Nakken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Brodie MJ, Mintzer S, Pack AM et al. Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia 2013; 54: 11\u2009\u2013\u200927. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23016553&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2012.03671.x","DOI":"10.1111\/j.1528-1167.2012.03671.x"},{"key":"ref=2","unstructured":"Statistikk fra Reseptregisteret. www.reseptregisteret.no (25.5.2014)."},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Tomson T, Battino D, Bonizzoni E et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10: 609\u2009\u2013\u200917. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21652013&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S1474-4422(11)70107-7","DOI":"10.1016\/S1474-4422(11)70107-7"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Johannessen Landmark C, Patsalos PN. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother 2010; 10: 119\u2009\u2013\u200940. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20021326&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1586\/ern.09.136","DOI":"10.1586\/ern.09.136"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Reimers A, Brodtkorb E, Sabers A. Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations. Seizure 2015; 28: 66\u2009\u2013\u200970. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25843765&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.seizure.2015.03.006","DOI":"10.1016\/j.seizure.2015.03.006"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Rosenfeld WE, Doose DR, Walker SA et al. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia 1997; 38: 317\u2009\u2013\u200923. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9070594&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1997.tb01123.x","DOI":"10.1111\/j.1528-1157.1997.tb01123.x"},{"key":"ref=7","unstructured":"Den norske legeforening. Retningslinjer for behandling av kvinner med epilepsi. Kapittel 2 Prevensjon. Konsensusrapport. Oslo: Den norske legeforening, 2011: 10\u2009\u2013\u200919."},{"key":"ref=8","unstructured":"Rabe T, Schwenkhagen A, Stodieck SRG. Kontrazeption und Schwangerschaft bei Frauen mit Epilepsie \u2013 eine Stellungnahme der DGGEF. J Reproduktionsmed Endokrinol 2010; 7: 159\u2009\u2013\u200978."},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Schwenkhagen AM, Stodieck SRG. Which contraception for women with epilepsy? Seizure 2008; 17: 145\u2009\u2013\u200950. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18178110&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.seizure.2007.11.013","DOI":"10.1016\/j.seizure.2007.11.013"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Aguglia U, Barboni G, Battino D et al. Italian consensus conference on epilepsy and pregnancy, labor and puerperium. Epilepsia 2009; 50 (suppl 1): 7\u2009\u2013\u200923. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19125842&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2008.01964.x","DOI":"10.1111\/j.1528-1167.2008.01964.x"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Guillemette T, Yount SM. Contraception and antiepileptic drugs. J Midwifery Womens Health 2012; 57: 290\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22587648&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1542-2011.2012.00180.x","DOI":"10.1111\/j.1542-2011.2012.00180.x"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Sidhu J, Job S, Singh S et al. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol 2006; 61: 191\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16433873&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1365-2125.2005.02539.x","DOI":"10.1111\/j.1365-2125.2005.02539.x"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Contin M, Albani F, Ambrosetto G et al. Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy. Epilepsia 2006; 47: 1573\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16981875&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2006.00558.x","DOI":"10.1111\/j.1528-1167.2006.00558.x"},{"key":"ref=14","unstructured":"Statens legemiddelverk. Preparatomtale (SPC) Lamictal. http:\/\/legemiddelverket.no\/legemiddelsok (18.11.2015)."},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Wegner I, Wilhelm AJ, Lambrechts DA et al. Effect of oral contraceptives on lamotrigine levels depends on comedication. Acta Neurol Scand 2014; 129: 393\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24571554&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/ane.12197","DOI":"10.1111\/ane.12197"},{"key":"ref=16","unstructured":"World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use (4th ed.). 2009. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241563888_eng.pdf?ua=1 (18.11.2015)."}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:34:02Z","timestamp":1781638442000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2016\/01\/klinisk-oversikt\/prevensjon-kvinner-som-bruker-antiepileptika"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,12]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1,12]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.14.1559","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,12]]}}}